October 20, 2021
FactCheck recently published insight from Rena Conti, Associate Professor in the Department of Markets, Public Policy and Law, on the topic of TV ads portraying false information regarding Medicare drug price negotiation. The article discusses these recent ads, paid for by Pharmaceutical Research and Manufacturers of America, which showcase misinformation regarding the federal government control over which medications people on Medicare can and cannot get. The pharmaceutical industry remains opposed to any effort to allow Medicare to negotiate drug prices.
The tv ads have raised speculation about some bills currently under consideration by lawmakers and touch on the debate of whether negotiation of drug prices for Medicare will result in a reduction in research and development in the drug industry. Rena explains that “this is not really reflective of any of the bills that we are aware of, or proposals that are on the table.”
- CBS (Boston): Workers are Calling it Quits by the Millions
- MIT Sloan Management Review: When We Don’t Own the Things We Use, Will We Still Love Them?
- BBC: Are Competitive Parents Compensating for Their Insecurities?
- China’s Tech Crackdown – Part 2: Reasserting Control Over a Growing Industry
- BU Today: Training for the Hybrid Office
- BBC: What We’re Getting Wrong About the ‘Great Resignation’
- Entergy New Orleans’ Failure to Protect its Power Grid and Customers Against Outages Following Hurricane Ida
- HR News: Workplace Diversity: 5 Benefits of an AI Recruitment Process
- This Week’s FDA Approval of E-Cigarettes: Throwing kids under the bus vs. abandoning adult smokers?
- China’s Tech Crackdown: Impact of Recent Regulatory Changes on the Tech Sector – Part 1